Stocks Moving From Alpha-Rich Ideas
Two weeks ago, GuruFundPicks argued that Thomson Creek may have reached an inflection point with its Q2 results. The stock is 10.5% since. Read article »
On July 9, fund manager Saj Karsan pointed out the huge discount on PineTree Capital's debentures. The debt is +24% since. Read article »
Breaking Alpha-Rich Ideas (for Pro Subscribers. Learn more»)
Janus: Abnormally High Returns On Invested Capital At A Low Multiple Of Free Cash Flow by Saidal Mohmand
Nuverra Environmental: A Sinking Ship With Default Risk by MBAvalueinvestor
Lee Enterprises' Shares May Double Again by Ted Barac
Squeeze Out Some Gains From Uranium One by Chris DeMuth Jr.
Long Ideas
Amazon Tests Satellite Network - Globalstar Poised For Launch by Mark Gomes
Why Berkshire's Discount To Intrinsic Value Will Close Soon by Asset Plays Investing
Potash Corp: Relax, Everything Will Be Just Fine by CJ Money Research
A Few Reasons Why Yandex Could Get Better by Nicholas Kitonyi
Constellation Energy Partners: New Ownership Is Transformational by Clayton Rulli
Updated Analysis Of The Bullish Case For Chefs' Warehouse by Pendulum
Updated Analysis Of The Bullish Case For Regal-Beloit by Pendulum
GSI Technology: Major Buyback And New Products On Tap Drives Further Upside by Ashraf Eassa
Golden Ocean: Compelling Buy With Multiple Upside Triggers by Street Smart Investor
Why Exxon Can't Afford To Let Shell Steal InterOil Or Its Resources by Resourcearb
Worldwide Lumia 1020 Initial Pricing Suggests Nokia Is Testing The Market by Chandan Sarkar
Ryland Homes: What To Do Now That The Stock Is 30% Off Its Highs by Money Investor
Movado Group: A Timeless Investment by Marshall Hargrave
AeroVironment Will Fly Again by Nathaniel Munson
Bob Evans Farms: The Value Is In The Pieces by Shaun Currie
Discussing Mr. Ballmer by John M. Mason
Cabela's: On The Hunt For Profits by Philip Saglimbeni
Kratos Defense & Security Solutions - A Small-Cap To Consider For A Portfolio by Michael Ugulini
Kronos: Record Sales Volumes Suggest A Big Rebound Soon by Nathan Rapport
Retrophin: A New Player In The Orphan And Ultra-Orphan Drug Spaces by Biotech Discoverer
Intel Still Has The Potential To Become A Leader Once Again by Yasir Idrees
Alexza Pharmaceuticals: Stage Set For Adasuve by Edison Investment Research
Cisco Justifies Shareholder Confidence In Its Stock by Liu Yanjun
Nokia's Delta Deal Is Delicious, And Missed By The Market Thus Far by Genesis Housing
Avalon Holdings: A Unique Way To Capitalize On The Oil & Gas Boom In Ohio, Pennsylvania by Edward Dostillio
Short Ideas
Ambarella: Channel Checks Point To Earnings Miss, Significant Downside by Eiad Asbahi
The Tesla Trade: Short Now, Buy Later? by Alex Colcernian
3 Reasons Alkaline Water Co. Will Soon Crash by Microcap Fraud Alert
Tesla Reminds Me Of Apple by Ashraf Eassa
University General Health Services: A Good Short by Christopher Drose
Even Elon Musk Thinks Tesla Stock Is Overpriced by David White
Quick Picks & Lists
Is There Any Substance To The Buyout Rumors Surrounding BioMarin And Catalyst? by george shrader
A Roadmap To Current Trends In The TV And Film Industries by Luis Sanchez
What Makes Altria Group A Good Buy? by The Analyst Hub
Why Some Investors Fail And 3 Top Stock Ideas by Valuentum
A Number Of Concerning Catalysts To Consider Before Creating A Position In Altria Group by Heather Ingrassia
Capitalizing On Cannabis: A Review Of Publicly-Traded Marijuana Stocks by Alan Brochstein
Insider Ownership
Insiders Are Buying Sarepta Therapeutics by Markus Aarnio
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario